precision medicine
Researchers say the completed sequencing of an entire human genome could one day bring further insights into genetic diseases.
Mayo Clinic announced an agreement on Tuesday, Oct. 12 that will allow it to offer clinical-grade comprehensive cancer genomic sequencing to cancer patients who choose to participate.